Push Admin

FDA gives hospital compassionate use permit for Ivermectin vs COVID-19

Article (news)

Jamaine Punzalan and Kristine Sabillo, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="http://sa.kapamilya.com/absnews/abscbnnews/media/2021/reuters/04/08/20210331-ivermectin.jpg"/><figcaption>A man holds the anti-parasite drug ivermectin after buying it with a medical prescription at a local pharmacy in Santa Cruz, Bolivia, May 19, 2020. Rodrigo Urzagasti, Reuters/File</figcaption></figure></div>MANILA — The Food and Drug Administration said on Thursday it granted a &quot;compassionate use permit&quot; to a hospital for the use of anti-parasite drug ivermectin to counter COVID-19, despite previous warning by international health organizations.Ivermectin is usually used to treat parasites in animals, according to an earlier FDA advisory.&quot;Ang pagkakaalam ko may isang ospital sa amin na nag-apply ng compassionate special permit for the use of ivermectin at ito po ay na-grant ngayong araw na ito,&quot; FDA Director General Eric Domingo said in a public briefing.(From what I know, a hospital applied for compassionate special permit for the use of ivermectin, and it was granted today.)Domingo declined to name the hospital &quot;out of patient privacy.&quot; Other hospitals that want to use ivermectin should secure separate compassionate use permit from the drug regulator, Domingo told ABS-CBN News in a text message. Groups that want to distribute a large number of the drug can apply under one permit, he added. A compassionate special permit allows experimental or unregistered drugs for limited off-label use. Acquiring such a permit does not mean, however, that the drug is proven to be effective since that requires clinical trial. Clinical trials for the use of ivermectin against COVID-19 are ongoing, said Domingo. The FDA has received 2 applications for certificate of product registration for the drug. The applicants were given a list of requirements, he said. &quot;Ito lang naman po ang laging sinasabi ng FDA, hindi po kami kontra sa ivermectin, kailangan lang po na irehistro ang produkto at dumaan lamang po sa tamang proseso ng pagsiguro po ng quality ng gamot na makakarating sa tao,&quot; Domingo said.(The FDA is only saying that we are not against ivermectin, but the product needs to be registered and go through the right process to ensure the safety of the drug that will reach the people.)Ivermectin recently made headlines after Anakalusugan Party-list Rep. Mike Defensor said he would <a href="https://news.abs-cbn.com/news/04/05/21/defensor-giving-away-veterinary-drug-ivermectin-to-covid-19-patients-despite-fda-warnings">distribute Ivermectin to the sick and elderly</a> in Quezon City, despite FDA warnings. <ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/04/06/21/palace-on-lawmakers-ivermectin-distribution-wait-for-regulator-approval">Palace on lawmaker&#x27;s ivermectin distribution: Wait for regulator approval</a></li></ul>Unauthorized use of veterinary drugs could lead to brain damage and death, infectious disease expert Dr. Edsel Maurice Salvana earlier said. The World Health Organization (WHO) last week recommended against using ivermectin in patients with COVID-19 except for clinical trials, because of a lack of data demonstrating its benefits.The recommendation follows the European Medicines Agency&#x27;s warning against the drug. The US Food and Drug Administration has also recommended it not be used for COVID-19.Merck, an ivermectin manufacturer, has also said its analysis did not support the drug&#x27;s safety and efficacy for COVID-19.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/04/02/21/who-joins-europe-merck-in-recommending-against-ivermectin-for-covid-19">WHO joins Europe, Merck in recommending against ivermectin for COVID-19</a></li></ul><div>— With a report from Reuters </div><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1657002" width="100%"></iframe></figure><div class="iwantbar">Video courtesy of PTV</div>

The Food and Drug Administration said on Thursday it granted a "compassionate use permit" to a hospital for the use of anti-parasite drug ivermectin to counter COVID-19, despite previous warning by international health organizations.

The Food and Drug Administration said on Thursday it granted a "compassionate use permit" to a hospital for the use of anti-parasite drug ivermectin to counter COVID-19, despite previous warning by international health organizations.

FDA gives hospital compassionate use permit for Ivermectin vs COVID-19

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

FDA gives hospital compassionate use permit for Ivermectin vs COVID-19

Jamaine Punzalan and Kristine Sabillo,

ABS-CBN News

Published Apr 08, 2021 12:12 PM PHT

|

Updated Apr 08, 2021 12:46 PM PHT

Read More:

FDA

FDA ivermectin

ivermectin

Mike Defensor

Mike Defensor ivermectin

COVID-19

COVID

coronavirus

coronavirus Philippines

COVID Philippines

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.